Can 5-FU be substituted for adjuvant capecitabine for a dialysis dependent patient with triple negative breast cancer s/p neoadjuvant chemotherapy followed by mastectomy showing small residual disease?
Answer from: Medical Oncologist at Academic Institution
I would not substitute 5-FU in this situation.Although the CREATE-X trial showed a survival benefit for adjuvant capecitabine in women who do not achieve pCR with neoadjuvant chemotherapy in a subset analysis of women with triple negative breast cancer, there are reasons to be concerned about these ...
Comments
Medical Oncologist at Agnesian Cancer Center Thank you.!
Medical Oncologist at Siri Onclogy and hematology Infusion Service The trials quoted do not represent the patient pop...
Thank you.!
The trials quoted do not represent the patient pop...